These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21771657)

  • 1. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.
    Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM
    Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines.
    Sorsa T; Tervahartiala T; Leppilahti J; Hernandez M; Gamonal J; Tuomainen AM; Lauhio A; Pussinen PJ; Mäntylä P
    Pharmacol Res; 2011 Feb; 63(2):108-13. PubMed ID: 20937384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.
    Golub LM; Elburki MS; Walker C; Ryan M; Sorsa T; Tenenbaum H; Goldberg M; Wolff M; Gu Y
    Int Dent J; 2016 Jun; 66(3):127-35. PubMed ID: 27009489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
    Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
    J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of non-antimicrobial tetracyclines in dermatology.
    Monk E; Shalita A; Siegel DM
    Pharmacol Res; 2011 Feb; 63(2):130-45. PubMed ID: 20937386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood.
    Cazalis J; Tanabe S; Gagnon G; Sorsa T; Grenier D
    Inflammation; 2009 Apr; 32(2):130-7. PubMed ID: 19238528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host modulation therapy with anti-inflammatory agents.
    Preshaw PM
    Periodontol 2000; 2018 Feb; 76(1):131-149. PubMed ID: 29193331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction and background.
    Golub LM
    Pharmacol Res; 2011 Feb; 63(2):99-101. PubMed ID: 20937387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.
    Elburki MS; Moore DD; Terezakis NG; Zhang Y; Lee HM; Johnson F; Golub LM
    J Periodontal Res; 2017 Apr; 52(2):186-200. PubMed ID: 27038334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease.
    Federici TJ
    Pharmacol Res; 2011 Dec; 64(6):614-23. PubMed ID: 21843641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
    Gürkan A; Cinarcik S; Hüseyinov A
    J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD).
    Caton J; Ryan ME
    Pharmacol Res; 2011 Feb; 63(2):114-20. PubMed ID: 21182947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase.
    Gu Y; Lee HM; Simon SR; Golub LM
    Pharmacol Res; 2011 Dec; 64(6):595-601. PubMed ID: 21651982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic.
    Payne JB; Golub LM
    Pharmacol Res; 2011 Feb; 63(2):121-9. PubMed ID: 20937388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
    Llavaneras A; Ramamurthy NS; Heikkilä P; Teronen O; Salo T; Rifkin BR; Ryan ME; Golub LM; Sorsa T
    J Periodontol; 2001 Aug; 72(8):1069-77. PubMed ID: 11525440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
    Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
    J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article.
    Ingman T; Sorsa T; Suomalainen K; Halinen S; Lindy O; Lauhio A; Saari H; Konttinen YT; Golub LM
    J Periodontol; 1993 Feb; 64(2):82-8. PubMed ID: 8433257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease.
    Tüter G; Kurtiş B; Serdar M; Aykan T; Okyay K; Yücel A; Toyman U; Pinar S; Cemri M; Cengel A; Walker SG; Golub LM
    J Clin Periodontol; 2007 Aug; 34(8):673-81. PubMed ID: 17590156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A herbal formula containing roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages through inhibition of nuclear factor κB (NFκB) pathway.
    Cheung DW; Koon CM; Wat E; Ko CH; Chan JY; Yew DT; Leung PC; Chan WY; Lau CB; Fung KP
    J Ethnopharmacol; 2013 Feb; 145(3):776-83. PubMed ID: 23261483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.